"Assisting You in Establishing Data Driven Brands"
The global diabetic socks market size was valued at USD 1.57 billion in 2025. The market is projected to grow from USD 1.65 billion in 2026 to USD 2.32 billion by 2034, exhibiting a CAGR of 4.34% during the forecast period.
Diabetic socks effectively protect users’ feet by preventing injuries, including blisters, ulcers, and others. These products feature a seamless design of extra padding and non-restrictive tops that improve blood flow in the feet and prevent foot injuries. Additionally, knee-length socks offer mild compression, which helps reduce the risk of leg injury. The increasing prevalence of diabetic disease and growing awareness of diabetic foot care among adults are driving the global diabetic-friendly socks market growth. According to the International Diabetes Foundation (IDF), by 2050, 1 in 8 people is projected to suffer from diabetes, with an increase of 46% from 2025 worldwide.
Key players operating in the worldwide market include medi GmbH & Company KG, Sigvaris Group, Essity AB, Juzo GmbH, and Thuasne Group. These players focus on launching footwear made from innovative material blends to better address the wound care needs of diabetic patients.
Technological Advancements in Development of Innovative Diabetic Socks to Drive Market Growth
Advancements in the development of diabetic-friendly socks made from moisture-wicking fibers, yarns with antimicrobial properties, and coatings are expected to increase demand among global diabetic patients, driving market growth. In addition, consistent manufacturers’ production of ulcer-treating socks equipped with embedded sensors that monitor skin temperature, pressure, and moisture changes is positively contributing to industry growth.
High Cost of Diabetic Socks to Restrain Market Growth
The higher cost of advanced materials used in the construction of specialized diabetic-friendly socks is limiting product demand. In addition, uncertainty in raw material availability and fluctuating prices is incurring additional production costs for the company, restraining the diabetic socks market growth. Besides, greater consumer accessibility to cheaper-priced non-medical socks is negatively impacting the consumption of diabetic-friendly wear globally.
Manufacturers’ Strategic Partnerships with Healthcare Providers to Create Newer Growth Opportunities
The consistent partnerships between manufacturers and healthcare clinics, hospitals, diabetic care centers, and insurers to enhance their product reach are creating new market growth opportunities. In addition, consistent doctors’ recommendations for the use of foot wound care products, including moisture-wicking socks, are driving global product sales.
Supply Chain Disruptions to Challenge Key Players’ International Business Expansion
In underdeveloped countries, a weak retail distribution network and a lack of product knowledge pose challenges to key companies in building their product sales. Additionally, uncertain transportation issues and rising freight charges are negatively impacting the business profitability of key players.
Rise of Digital Health & Telemedicine Integration to Favor Growth
The emergence of Remote Patient Monitoring (RPM) tools and the growing number of innovators integrating telemedicine services into digital healthcare systems and applications increase the product usage recommendations by doctors, favoring market growth. Furthermore, the early identification of foot abnormalities through remote or physical health care check-ups increases diabetic patients’ purchases of foot-friendly socks, creating new industry growth prospects.
Download Free sample to learn more about this report.
Wider Adoption and Greater Safety Perception of Non-Compression Socks Led to Dominance of Segment
By type, the market is bifurcated into compression and non-compression.
The non-compression segment exhibited a leading global diabetic socks market share of 56.83% in 2025. Wider consumer adoption and greater safety perception of the non-compression socks, compared to the counterpart product type. In addition, consistent doctors' recommendations for the use of non-compression socks, which support advanced naturopathy, sensitive skin, swelling, and peripheral arterial disease (PAD) treatments, are driving the segment’s growth.
The compression segment is projected to grow at the fastest CAGR of 4.73% from 2026 to 2034. The fastest growth of the compression segment is attributed to consistent technological innovations and evolving foot care models globally.
To know how our report can help streamline your business, Speak to Analyst
Mid-range Segment Led Due to Its Optimal Balance between Affordability and Functional Performance
By price, the market is segmented into economy, mid-range, and premium. The mid-range segment exhibited a leading global market share of 43.76% in 2025. A high number of patients prefer socks that exhibit minimalist functionalities and are available at affordable prices. The segment’s leading share is attributed to the optimal balance between comfort, affordability, and functional performance of the products that fall into the mid-price range. Furthermore, consistent recommendations from pharmacy stores and healthcare professionals for the use of high-quality products at mid-range prices are driving the segment’s growth.
The premium segment is projected to grow at the fastest rate of 5.10% from 2026 to 2034. The segment’s fastest growth is attributed to the rising adoption of luxury wearables among upper-income consumer groups worldwide. The increasing demand for diabetic-friendly socks made of premium, custom-fabric technology and functionalities is favoring the segment’s growth.
High Diabetes Prevalence among Men Led to Segment’s Dominance
Based on end-user, the market is divided into men, women, and kids. The men segment exhibited a leading global market share of 46.23% in 2025. The segment’s leading share is attributed to the high prevalence of diabetes and the related complications among men consumers worldwide. In addition, the rising demand from men consumers for socks providing clinically-proven benefits, including cushioning, moisture management, and blood circulation support, is favoring the segment’s growth.
The kids segment is projected to grow at the fastest rate of 5.13% from 2026 to 2034. The segment’s fastest growth is attributed to the rising number of kids & adolescents suffering from Type 1 diabetes and growing awareness about product knowledge globally. In addition, the growing number of manufacturers expanding their product portfolios with child-specific designs, appropriate sizing, and softer fabrics is positively contributing to the segment’s growth.
Higher Healthcare Professionals’ Recommendations of Product Purchase from Pharmacy Stores Led to Segment’s Dominance
Based on distribution channel, the market is segmented into specialty stores, pharmacy stores, online channels, and others.
The pharmacy stores segment exhibited a leading global market share of 36.70% in 2025. The segment’s leading share is attributed to the higher recommendations from healthcare professionals for the purchase of diabetic-friendly socks from pharmacy stores, providing better product guidance globally. Additionally, the growing infrastructure of pharmacy stores is positively contributing to the segment’s growth.
The online channels segment is projected to grow at the fastest rate of 5.73% from 2026 to 2034. Its fastest growth is attributed to the emergence of digital healthcare applications offering products at discounted rates worldwide.
By geography, the market is categorized into North America, Europe, Asia Pacific, South America, and the Middle East & Africa.
Asia Pacific Diabetic Socks Market Size, 2025 (USD Billion) To get more information on the regional analysis of this market, Download Free sample
The Asia Pacific region exhibited a leading global market share of 38.88% in 2025. The region’s market size reached USD 0.65 billion in 2026. The region’s market is projected to grow at the fastest rate of 5.53% from 2026 to 2034. Increasing demand for smart socks and rising online shopping adoption are driving the market expansion. Besides, a high number of people suffering from diabetes and preferring advanced healthcare solutions across India and China is generating considerable product revenues in the region. Furthermore, the emergence of diabetes care programs recommending that their patients use diabetes-friendly socks for foot care management is positively contributing to market growth in the region.
The North American region is projected to exhibit a second leading global market position throughout the forecast period of 2026-2034. Significant healthcare spending and higher prevalence of peripheral neuropathy and poor circulation among the population are generating considerable product sales across the U.S. and Canada. In addition, the rising adoption of clinically recommended socks made from innovative technologies and premium-quality materials is driving market growth.
The U.S. market size reached USD 0.38 billion in 2025. The greater healthcare infrastructure and high number of physicians recommending the use of diabetic-friendly socks are generating considerable product revenues across the U.S. In addition, an increasing number of firms operating digital healthcare applications are partnering with pharmacy stores to expand their brand reach, driving market growth across the U.S.
The European region exhibited a third-leading global market share during 2026-2034. The increasing aging population and growing adult consumer demand for foot wound care products, including socks, are driving the market. In addition, the consistent launch of national diabetes associations and public health programs' healthcare campaigns highlighting the importance of using foot care products is driving product demand across the region.
The market in the South America and Middle East & Africa regions is expected to witness a moderate growth rate from 2026 to 2034. The South America market reached a valuation of USD 0.034 billion in 2025. The growing awareness of diabetes-friendly socks and the increasing disposable income of consumers in Brazil, Argentina, and Colombia are primarily driving the market growth.
The growing number of hospitals and other healthcare infrastructure facilities recommending product usage is driving market growth in the Middle East & African region. In the Middle East & African market, South Africa reached a market value of USD 0.010 billion in 2025.
Consistent Focus on Partnerships with Retailers to Help Key Players Maintain Market Positions
The key players operating in the global market include medi GmbH & Company KG, Sigvaris Group, Essity AB, Juzo GmbH, and Thuasne Group. These players consistently focus on partnering with pharmacy retailing stores to strengthen their product reach. Additionally, they collaborate with healthcare professionals to educate their consumers about the benefits and features of their products. For instance, medi GmbH & Company KG consistently hires new healthcare professionals to provide healthcare solutions to their customers.
To gain extensive insights into the market, Download for Customization
|
ATTRIBUTE |
DETAILS |
|
Study Period |
2021-2034 |
|
Base Year |
2025 |
|
Estimated Year |
2026 |
|
Forecast Period |
2026-2034 |
|
Historical Period |
2021-2024 |
|
Growth Rate |
CAGR of 4.34% from 2026-2034 |
|
Unit |
Value (USD Billion) |
|
Segmentation |
By Type, Price, End-User, Distribution Channel, and Region |
|
By Type |
· Compression · Non-Compression |
|
By Price |
· Economy · Mid-Range · Premium |
|
By End-User |
· Men · Women · Kids |
|
By Distribution Channel |
· Specialty Stores · Pharmacy Stores · Online Channels · Others |
|
By Region |
· North America (By Type, Price, End-User, Distribution Channel, and Country) o U.S. (By Type) o Canada (By Type) o Mexico (By Type) · Europe (By Type, Price, End-User, Distribution Channel, and Country) o Germany (By Type) o France (By Type) o Italy (By Type) o Spain (By Type) o U.K. (By Type) o Russia (By Type) o Rest of Europe (By Type) · Asia Pacific (By Type, Price, End-User, Distribution Channel, and Country) o China (By Type) o India (By Type) o Japan (By Type) o Australia (By Type) o Rest of Asia Pacific (By Type) · South America (By Type, Price, End-User, Distribution Channel, and Country) o Brazil (By Type) o Argentina (By Type) o Rest of South America (By Type) · Middle East & Africa (By Type, Price, End-User, Distribution Channel, and Country) o South Africa (By Type) o UAE (By Type) o Rest of Middle East & Africa (By Type) |
Fortune Business Insights says that the global market value stood at USD 1.57 billion in 2025 and is projected to reach USD 2.32 billion by 2034.
In 2025, the market value stood at USD 0.61 billion.
At a CAGR of 4.34%, the global market forecasted to growth during 2026-2034.
By type, the non-compression segment led the market.
Technological advancements in the development of innovative diabetic socks are driving market growth.
medi GmbH & Company KG, Sigvaris Group, Essity AB, Juzo GmbH, and Thuasne Group are among the prominent players in the market.
Asia Pacific dominated the market in 2025.
Manufacturers strategic partnerships with healthcare providers are expected to favor the product adoption rate.
Related Reports
Get In Touch With Us
US +1 833 909 2966 ( Toll Free )